Nils Lonberg insider trades
Open-market stock purchases and sales by Nils Lonberg, Director at Bicara Therapeutics Inc, from SEC Form 4 filings since Sep 12, 2024.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- BCAX Bicara Therapeutics Inc: other filings, last Jun 9, 2025